{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:37:23Z","timestamp":1790415443209,"version":"4.1.0"},"reference-count":160,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN-143210"],"award-info":[{"award-number":["FDN-143210"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.bbrc.2016.07.058","type":"journal-article","created":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T14:03:22Z","timestamp":1468677802000},"page":"1051-1062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Striatal synaptic dysfunction and altered calcium regulation in Huntington disease"],"prefix":"10.1016","volume":"483","author":[{"given":"Lynn A.","family":"Raymond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2016.07.058_bib1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/BST0380443","article-title":"Synaptopathy: dysfunction of synaptic function?","volume":"38","author":"Brose","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbrc.2016.07.058_bib2","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1582-4934.2006.tb00439.x","article-title":"Synaptic dysfunction and oxidative stress in Alzheimer's disease: emerging mechanisms","volume":"10","author":"Forero","year":"2006","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.bbrc.2016.07.058_bib3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.tins.2010.08.002","article-title":"Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease","volume":"33","author":"Milnerwood","year":"2010","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuroscience.2012.05.043","article-title":"Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington's disease","volume":"251","author":"Nithianantharajah","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbrc.2016.07.058_bib5","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/mds.26620","article-title":"Early synaptic dysfunction in Parkinson's disease: insights from animal models","volume":"31","author":"Schirinzi","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbrc.2016.07.058_bib6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A\u00a0novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2016.07.058_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ajmg.b.30992","article-title":"CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches","volume":"153B","author":"Langbehn","year":"2010","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatr. Genet."},{"key":"10.1016\/j.bbrc.2016.07.058_bib8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1750-3639.1992.tb00709.x","article-title":"New insights into the clinical features, pathogenesis and molecular genetics of Huntington disease","volume":"2","author":"Kremer","year":"1992","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbrc.2016.07.058_bib9","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.bbrc.2016.07.058_bib10","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/jnnp-2012-304636","article-title":"Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records","volume":"84","author":"Evans","year":"2013","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbrc.2016.07.058_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/mds.25717","article-title":"Multisource ascertainment of Huntington disease in Canada: prevalence and population at risk","volume":"29","author":"Fisher","year":"2014","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.bbrc.2016.07.058_bib12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbrc.2016.07.058_bib13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbrc.2016.07.058_bib14","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2016.07.058_bib15","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/mds.25964","article-title":"HD-CAB: a cognitive assessment battery for clinical trials in Huntington's disease 1,2,3","volume":"29","author":"Stout","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbrc.2016.07.058_bib16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1176\/appi.ajp.2015.14121551","article-title":"Longitudinal psychiatric symptoms in prodromal Huntington's disease: a decade of data","volume":"173","author":"Epping","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbrc.2016.07.058_bib17","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbrc.2016.07.058_bib18","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fnagi.2014.00078","article-title":"Clinical and biomarker changes in premanifest huntington disease show trial feasibility: a decade of the predict-HD study","volume":"6","author":"Paulsen","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib19","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","article-title":"Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data","volume":"12","author":"Tabrizi","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbrc.2016.07.058_bib20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/mds.26118","article-title":"A\u00a0longitudinal study of magnetic resonance spectroscopy Huntington's disease biomarkers","volume":"30","author":"Sturrock","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbrc.2016.07.058_bib21","doi-asserted-by":"crossref","first-page":"12166","DOI":"10.1038\/srep12166","article-title":"Ultrasensitive measurement of huntingtin protein in cerebrospinal fluid demonstrates increase with Huntington disease stage and decrease following brain huntingtin suppression","volume":"5","author":"Southwell","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2016.07.058_bib22","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1172\/JCI80743","article-title":"Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients","volume":"125","author":"Wild","year":"2015","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.bbrc.2016.07.058_bib23","first-page":"2179","article-title":"Transgenic animal models for study of the pathogenesis of Huntington's disease and therapy","volume":"9","author":"Chang","year":"2015","journal-title":"Drug Des. Devel Ther."},{"issue":"5","key":"10.1016\/j.bbrc.2016.07.058_bib24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/FBP.0000000000000217","article-title":"Of rodents and men: understanding the emergence of motor and cognitive symptoms in Huntington disease","volume":"27","author":"Abada","year":"2016","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.bbrc.2016.07.058_bib25","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nrn3570","article-title":"Choosing an animal model for the study of Huntington's disease","volume":"14","author":"Pouladi","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2016.07.058_bib27","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.4161\/rna.26706","article-title":"Aberrantly spliced HTT, a new player in Huntington's disease pathogenesis","volume":"10","author":"Gipson","year":"2013","journal-title":"RNA Biol."},{"key":"10.1016\/j.bbrc.2016.07.058_bib28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","article-title":"A\u00a0YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration","volume":"23","author":"Hodgson","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2016.07.058_bib29","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.07.058_bib30","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesiss in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib31","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1093\/hmg\/ddt203","article-title":"Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntington's disease","volume":"22","author":"Hult Lundh","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.07.058_bib32","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","article-title":"Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease","volume":"25","author":"Van Raamsdonk","year":"2005","journal-title":"J.\u00a0Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib33","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neuroscience.2008.08.041","article-title":"Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice","volume":"157","author":"Hickey","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbrc.2016.07.058_bib34","doi-asserted-by":"crossref","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175","volume":"7","author":"Menalled","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2016.07.058_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cne.10776","article-title":"Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats","volume":"465","author":"Menalled","year":"2003","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.bbrc.2016.07.058_bib36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/9.4.503","article-title":"Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice","volume":"9","author":"Wheeler","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.07.058_bib37","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.drudis.2014.02.014","article-title":"The many faces of autophagy dysfunction in Huntington's disease: from mechanism to therapy","volume":"19","author":"Cortes","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbrc.2016.07.058_bib38","doi-asserted-by":"crossref","first-page":"13662","DOI":"10.1523\/JNEUROSCI.4144-08.2008","article-title":"Enhanced sensitivity of striatal neurons to axonal transport defects induced by mutant huntingtin","volume":"28","author":"Her","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib39","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.drudis.2014.03.016","article-title":"Transcriptional dysregulation in Huntington's disease: a failure of adaptive transcriptional homeostasis","volume":"19","author":"Kumar","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbrc.2016.07.058_bib40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.expneurol.2012.08.010","article-title":"Axonopathy in Huntington's disease","volume":"246","author":"Li","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbrc.2016.07.058_bib41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tins.2014.09.003","article-title":"Autophagy in Huntington disease and huntingtin in autophagy","volume":"38","author":"Martin","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib42","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","article-title":"Brain-derived neurotrophic factor in neurodegenerative diseases","volume":"5","author":"Zuccato","year":"2009","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbrc.2016.07.058_bib43","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1371\/journal.pgen.0030082","article-title":"Huntingtin interacting proteins are genetic modifiers of neurodegeneration","volume":"3","author":"Kaltenbach","year":"2007","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbrc.2016.07.058_bib44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuron.2012.05.024","article-title":"Network organization of the huntingtin proteomic interactome in mammalian brain","volume":"75","author":"Shirasaki","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2016.07.058_bib45","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1242\/dmm.017368","article-title":"Huntingtin is required for ER-to-Golgi transport and for secretory vesicle fusion at the plasma membrane","volume":"7","author":"Brandstaetter","year":"2014","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.bbrc.2016.07.058_bib46","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0896-6273(95)90346-1","article-title":"Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons","volume":"14","author":"DiFiglia","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2016.07.058_bib47","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pneurobio.2006.11.001","article-title":"The corticostriatal pathway in Huntington's disease","volume":"81","author":"Cepeda","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbrc.2016.07.058_bib48","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuroscience.2011.08.052","article-title":"Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function","volume":"198","author":"Raymond","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbrc.2016.07.058_bib49","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1523\/JNEUROSCI.23-03-00961.2003","article-title":"Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease","volume":"23","author":"Cepeda","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib50","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1523\/JNEUROSCI.5687-08.2009","article-title":"Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease","volume":"29","author":"Joshi","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib51","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1523\/JNEUROSCI.2011-10.2011","article-title":"Increased neurotransmitter release at the neuromuscular junction in a mouse model of polyglutamine disease","volume":"31","author":"Rozas","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib52","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0361-9230(01)00611-6","article-title":"Abnormalities in the synaptic vesicle fusion machinery in Huntington's disease","volume":"56","author":"Morton","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbrc.2016.07.058_bib53","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1093\/hmg\/ddu166","article-title":"Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington's disease","volume":"23","author":"Smith","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.07.058_bib54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1471-4159.2007.04703.x","article-title":"Loss of SNAP-25 and rabphilin 3a in sensory-motor cortex in Huntington's disease","volume":"103","author":"Smith","year":"2007","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.bbrc.2016.07.058_bib55","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JHD-130080","article-title":"Striatal synaptosomes from Hdh140Q\/140Q knock-in mice have altered protein levels, novel sites of methionine oxidation, and excess glutamate release after stimulation","volume":"2","author":"Valencia","year":"2013","journal-title":"J.\u00a0Huntingt. Dis."},{"key":"10.1016\/j.bbrc.2016.07.058_bib56","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.nbd.2015.11.020","article-title":"Differential changes in thalamic and cortical excitatory synapses onto striatal spiny projection neurons in a Huntington disease mouse model","volume":"86","author":"Kolodziejczyk","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2016.07.058_bib57","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1113\/jphysiol.2007.142448","article-title":"Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load","volume":"585","author":"Milnerwood","year":"2007","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.bbrc.2016.07.058_bib58","doi-asserted-by":"crossref","first-page":"33719","DOI":"10.1074\/jbc.M111.236521","article-title":"Impaired alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor trafficking and function by mutant huntingtin","volume":"286","author":"Mandal","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2016.07.058_bib59","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.nbd.2015.12.009","article-title":"Impaired development of cortico-striatal synaptic connectivity in a cell culture model of Huntington's disease","volume":"87","author":"Buren","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2016.07.058_bib60","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1523\/JNEUROSCI.4356-06.2007","article-title":"Altered NMDA receptor trafficking in a yeast artificial chromosome transgenic mouse model of Huntington's disease","volume":"27","author":"Fan","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib61","doi-asserted-by":"crossref","first-page":"e00036","DOI":"10.1042\/AN20100007","article-title":"Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington's disease","volume":"2","author":"Cummings","year":"2010","journal-title":"ASN Neuro"},{"key":"10.1016\/j.bbrc.2016.07.058_bib62","doi-asserted-by":"crossref","first-page":"e50717","DOI":"10.1371\/journal.pone.0050717","article-title":"Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease","volume":"7","author":"Heikkinen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2016.07.058_bib63","doi-asserted-by":"crossref","first-page":"e94562","DOI":"10.1371\/journal.pone.0094562","article-title":"Striatal synaptic dysfunction and hippocampal plasticity deficits in the Hu97\/18 mouse model of Huntington disease","volume":"9","author":"Kolodziejczyk","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2016.07.058_bib64","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nbd.2013.08.009","article-title":"Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice","volume":"60","author":"Deng","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2016.07.058_bib65","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fnsys.2014.00198","article-title":"Differential loss of thalamostriatal and corticostriatal input to striatal projection neuron types prior to overt motor symptoms in the Q140 knock-in mouse model of Huntington's disease","volume":"8","author":"Deng","year":"2014","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib66","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1093\/hmg\/ddr308","article-title":"Altered palmitoylation and neuropathological deficits in mice lacking HIP14","volume":"20","author":"Singaraja","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.07.058_bib67","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.nbd.2011.03.018","article-title":"Natural history of disease in the YAC128 mouse reveals a discrete signature of pathology in Huntington disease","volume":"43","author":"Carroll","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2016.07.058_bib68","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1093\/hmg\/ddv248","article-title":"Analysis of YFP(J16)-R6\/2 reporter mice and postmortem brains reveals early pathology and increased vulnerability of callosal axons in Huntington's disease","volume":"24","author":"Gatto","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.07.058_bib69","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1016\/j.neuroimage.2009.10.015","article-title":"Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical \u201cdisconnection\u201d","volume":"49","author":"Rosas","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.bbrc.2016.07.058_bib70","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1093\/hmg\/ddg218","article-title":"Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release","volume":"12","author":"Li","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.07.058_bib71","doi-asserted-by":"crossref","first-page":"11251","DOI":"10.1038\/ncomms11251","article-title":"Real-time imaging of glutamate clearance reveals normal striatal uptake in Huntington disease mouse models","volume":"7","author":"Parsons","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2016.07.058_bib72","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1523\/JNEUROSCI.11-12-03877.1991","article-title":"Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry","volume":"11","author":"Ferrante","year":"1991","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib73","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.3155875","article-title":"Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease","volume":"227","author":"Graveland","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2016.07.058_bib74","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1152\/jn.2001.86.6.2667","article-title":"Electrophysiological and morphological changes in striatal spiny neurons in R6\/2 Huntington's disease transgenic mice","volume":"86","author":"Klapstein","year":"2001","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.bbrc.2016.07.058_bib75","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1523\/JNEUROSCI.21-23-09112.2001","article-title":"Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease","volume":"21","author":"Laforet","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib76","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1523\/JNEUROSCI.1038-15.2016","article-title":"Enhanced store-operated calcium entry leads to striatal synaptic loss in a Huntington's disease mouse model","volume":"36","author":"Wu","year":"2016","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib77","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.nbd.2003.08.024","article-title":"Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation","volume":"14","author":"Luthi-Carter","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2016.07.058_bib78","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.nbd.2007.11.006","article-title":"Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice","volume":"29","author":"Nithianantharajah","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2016.07.058_bib79","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fncel.2014.00160","article-title":"The NMDA receptor complex: a multifunctional machine at the glutamatergic synapse","volume":"8","author":"Fan","year":"2014","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib80","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders","volume":"11","author":"Hardingham","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib81","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn3504","article-title":"NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease","volume":"14","author":"Paoletti","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib82","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuron.2014.03.030","article-title":"Extrasynaptic NMDA receptor involvement in central nervous system disorders","volume":"82","author":"Parsons","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2016.07.058_bib83","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/361031a0","article-title":"A\u00a0synaptic model of memory: long-term potentiation in the hippocampus","volume":"361","author":"Bliss","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2016.07.058_bib84","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1007\/s11064-013-0987-2","article-title":"NMDA receptor activation: two targets for two co-agonists","volume":"38","author":"Henneberger","year":"2013","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbrc.2016.07.058_bib85","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1152\/jn.01044.2006","article-title":"Modulation of NMDA receptor properties and synaptic transmission by the NR3A subunit in mouse hippocampal and cerebrocortical neurons","volume":"99","author":"Tong","year":"2008","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.bbrc.2016.07.058_bib86","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1152\/jn.00308.2004","article-title":"Enhanced striatal NR2B-containing N-methyl-D-aspartate receptor-mediated synaptic currents in a mouse model of Huntington disease","volume":"92","author":"Li","year":"2004","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.bbrc.2016.07.058_bib87","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1074\/jbc.M110.182600","article-title":"Triheteromeric NR1\/NR2A\/NR2B receptors constitute the major N-methyl-D-aspartate receptor population in adult hippocampal synapses","volume":"286","author":"Rauner","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2016.07.058_bib88","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/(SICI)1096-9861(20000417)419:4<407::AID-CNE1>3.0.CO;2-I","article-title":"Expression of NMDA receptor subunit mRNAs in neurochemically identified projection and interneurons in the human striatum","volume":"419","author":"Kuppenbender","year":"2000","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.bbrc.2016.07.058_bib89","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0306-4522(96)00089-9","article-title":"The messenger RNAs for the N-methyl-D-aspartate receptor subunits show region-specific expression of different subunit composition in the human brain","volume":"73","author":"Rigby","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbrc.2016.07.058_bib90","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1046\/j.1471-4159.1999.0721890.x","article-title":"Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin","volume":"72","author":"Chen","year":"1999","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.bbrc.2016.07.058_bib91","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pneurobio.2006.11.003","article-title":"N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease","volume":"81","author":"Fan","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbrc.2016.07.058_bib92","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2016.07.058_bib93","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","article-title":"Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice","volume":"65","author":"Milnerwood","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2016.07.058_bib94","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.nbd.2012.05.013","article-title":"Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice","volume":"48","author":"Milnerwood","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2016.07.058_bib95","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.nbd.2013.11.013","article-title":"Chronic blockade of extrasynaptic NMDA receptors ameliorates synaptic dysfunction and pro-death signaling in Huntington disease transgenic mice","volume":"62","author":"Dau","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2016.07.058_bib96","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.nbd.2011.12.019","article-title":"P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease","volume":"45","author":"Fan","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2016.07.058_bib97","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/jnc.12700","article-title":"Alterations in STriatal-Enriched protein tyrosine Phosphatase expression, activation, and downstream signaling in early and late stages of the YAC128 Huntington's disease mouse model","volume":"130","author":"Gladding","year":"2014","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.bbrc.2016.07.058_bib98","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1093\/hmg\/dds154","article-title":"Calpain and STriatal-Enriched protein tyrosine phosphatase (STEP) activation contribute to extrasynaptic NMDA receptor localization in a Huntington's disease mouse model","volume":"21","author":"Gladding","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.07.058_bib99","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nm.2056","article-title":"Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin","volume":"15","author":"Okamoto","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2016.07.058_bib100","article-title":"Differential synaptic and extrasynaptic glutamate-receptor alterations in striatal medium-sized spiny neurons of aged YAC128 Huntington's disease mice","volume":"6","author":"Botelho","year":"2014","journal-title":"PLoS Curr."},{"key":"10.1016\/j.bbrc.2016.07.058_bib101","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2014.05.032","article-title":"Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington's disease","volume":"83","author":"Plotkin","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2016.07.058_bib102","doi-asserted-by":"crossref","first-page":"10928","DOI":"10.1523\/JNEUROSCI.2491-09.2009","article-title":"Interaction of postsynaptic density protein-95 with NMDA receptors influences excitotoxicity in the yeast artificial chromosome mouse model of Huntington's disease","volume":"29","author":"Fan","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib103","doi-asserted-by":"crossref","first-page":"24713","DOI":"10.1074\/jbc.M103501200","article-title":"Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95","volume":"276","author":"Sun","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2016.07.058_bib104","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/nm.3246","article-title":"Suppressing aberrant GluN3A expression rescues synaptic and behavioral impairments in Huntington's disease models","volume":"19","author":"Marco","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2016.07.058_bib105","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1007\/s00018-015-1937-8","article-title":"Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease","volume":"72","author":"Takahashi","year":"2015","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib106","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/0896-6273(94)90057-4","article-title":"Block of glutamate transporters potentiates postsynaptic excitation","volume":"13","author":"Tong","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2016.07.058_bib107","doi-asserted-by":"crossref","first-page":"7821","DOI":"10.1523\/JNEUROSCI.1697-04.2004","article-title":"Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression","volume":"24","author":"Massey","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib108","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/brain\/awf180","article-title":"Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation","volume":"125","author":"Behrens","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.bbrc.2016.07.058_bib109","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1006\/nbdi.2001.0430","article-title":"Impaired glutamate uptake in the R6 Huntington's disease transgenic mice","volume":"8","author":"Lievens","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2016.07.058_bib110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.nbd.2010.05.027","article-title":"Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington disease","volume":"40","author":"Huang","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2016.07.058_bib111","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.neuroscience.2008.02.004","article-title":"Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6\/2 mouse","volume":"153","author":"Miller","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbrc.2016.07.058_bib112","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1126\/science.1359647","article-title":"The time course of glutamate in the synaptic cleft","volume":"258","author":"Clements","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2016.07.058_bib113","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1523\/JNEUROSCI.4255-14.2015","article-title":"Conditional deletion of the glutamate transporter GLT-1 reveals that astrocytic GLT-1 protects against fatal epilepsy while neuronal GLT-1 contributes significantly to glutamate uptake into synaptosomes","volume":"35","author":"Petr","year":"2015","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib114","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1523\/JNEUROSCI.0316-16.2016","article-title":"Functional indicators of glutamate transport in single striatal astrocytes and the influence of Kir4.1 in normal and huntington mice","volume":"36","author":"Dvorzhak","year":"2016","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib115","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1523\/JNEUROSCI.3693-15.2016","article-title":"Dysfunctional calcium and glutamate signaling in striatal astrocytes from Huntington's disease model mice","volume":"36","author":"Jiang","year":"2016","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib116","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nmeth.2333","article-title":"An optimized fluorescent probe for visualizing glutamate neurotransmission","volume":"10","author":"Marvin","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bbrc.2016.07.058_bib117","doi-asserted-by":"crossref","first-page":"e00033","DOI":"10.1042\/AN20090058","article-title":"Genetic mouse models of Huntington's disease: focus on electrophysiological mechanisms","volume":"2","author":"Cepeda","year":"2010","journal-title":"ASN Neuro"},{"key":"10.1016\/j.bbrc.2016.07.058_bib118","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1523\/JNEUROSCI.2137-12.2013","article-title":"Multiple sources of striatal inhibition are differentially affected in Huntington's disease mouse models","volume":"33","author":"Cepeda","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib119","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/jnr.20344","article-title":"Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF","volume":"78","author":"Cepeda","year":"2004","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.bbrc.2016.07.058_bib120","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1113\/jphysiol.2012.241018","article-title":"Tonic mGluR5\/CB1-dependent suppression of inhibition as a pathophysiological hallmark in the striatum of mice carrying a mutant form of huntingtin","volume":"591","author":"Dvorzhak","year":"2013","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.bbrc.2016.07.058_bib121","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.nbd.2011.12.017","article-title":"Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington's disease","volume":"45","author":"Chiodi","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2016.07.058_bib122","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.nbd.2014.08.009","article-title":"Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice","volume":"71","author":"Naydenov","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2016.07.058_bib123","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.conb.2005.08.001","article-title":"Modulation of neuronal protein trafficking and function by palmitoylation","volume":"15","author":"Huang","year":"2005","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.bbrc.2016.07.058_bib124","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.pneurobio.2011.11.002","article-title":"Putting proteins in their place: palmitoylation in Huntington disease and other neuropsychiatric diseases","volume":"97","author":"Young","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbrc.2016.07.058_bib125","doi-asserted-by":"crossref","first-page":"e1004405","DOI":"10.1371\/journal.pcbi.1004405","article-title":"Curation of the mammalian palmitoylome indicates a pivotal role for palmitoylation in diseases and disorders of the nervous system and cancers","volume":"11","author":"Sanders","year":"2015","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.bbrc.2016.07.058_bib126","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nature07605","article-title":"Neural palmitoyl-proteomics reveals dynamic synaptic palmitoylation","volume":"456","author":"Kang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2016.07.058_bib127","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1042\/BST20140242","article-title":"Aberrant palmitoylation in Huntington disease","volume":"43","author":"Sanders","year":"2015","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbrc.2016.07.058_bib128","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/hmg\/dds441","article-title":"Hip14l-deficient mice develop neuropathological and behavioural features of Huntington disease","volume":"22","author":"Sutton","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.07.058_bib129","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1152\/jn.00791.2004","article-title":"Striatal potassium channel dysfunction in Huntington's disease transgenic mice","volume":"93","author":"Ariano","year":"2005","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.bbrc.2016.07.058_bib130","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nn.3691","article-title":"Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice","volume":"17","author":"Tong","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib131","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1021\/cn500100r","article-title":"Astrocytes and Huntington's disease","volume":"5","author":"Khakh","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib132","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0168-0102(96)01065-6","article-title":"Calcium-binding proteins in primate basal ganglia","volume":"25","author":"Parent","year":"1996","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.bbrc.2016.07.058_bib133","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0006-8993(00)02135-1","article-title":"Striatal interneurons expressing calretinin, parvalbumin or NADPH-diaphorase: a comparative study in the rat, monkey and human","volume":"863","author":"Wu","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.bbrc.2016.07.058_bib134","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1750-1326-6-81","article-title":"Dantrolene is neuroprotective in Huntington's disease transgenic mouse model","volume":"6","author":"Chen","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbrc.2016.07.058_bib135","doi-asserted-by":"crossref","first-page":"13614","DOI":"10.1523\/JNEUROSCI.3455-07.2007","article-title":"Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington's disease","volume":"27","author":"Fernandes","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib136","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1460-9568.2010.07268.x","article-title":"Glutamate-induced alterations in Ca2+ signaling are modulated by mitochondrial Ca2+ handling capacity in brain slices of R6\/1 transgenic mice","volume":"32","author":"Rosenstock","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib137","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1073\/pnas.0409402102","article-title":"Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease","volume":"102","author":"Tang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2016.07.058_bib138","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.nbd.2008.03.010","article-title":"Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease","volume":"31","author":"Zhang","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2016.07.058_bib139","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.nbd.2015.09.008","article-title":"Mitochondrial dynamics and quality control in Huntington's disease","volume":"90","author":"Guedes-Dias","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2016.07.058_bib140","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0006-8993(95)00901-2","article-title":"Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington's disease","volume":"697","author":"Borlongan","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.bbrc.2016.07.058_bib141","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1073\/pnas.92.15.7105","article-title":"Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates","volume":"92","author":"Brouillet","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2016.07.058_bib142","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1093\/hmg\/ddi319","article-title":"HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism","volume":"14","author":"Seong","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.07.058_bib143","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib144","doi-asserted-by":"crossref","first-page":"34785","DOI":"10.1074\/jbc.M603845200","article-title":"Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences","volume":"281","author":"Milakovic","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2016.07.058_bib145","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1074\/jbc.M704704200","article-title":"Calcium homeostasis and mitochondrial dysfunction in striatal neurons of Huntington disease","volume":"283","author":"Lim","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2016.07.058_bib146","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddw138","article-title":"Oxygen consumption deficit in Huntington disease mouse brain under metabolic stress","author":"Lou","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.07.058_bib147","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1093\/hmg\/ddv209","article-title":"Oxidative metabolism in YAC128 mouse model of Huntington's disease","volume":"24","author":"Hamilton","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2016.07.058_bib148","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2016.07.058_bib149","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.freeradbiomed.2013.04.016","article-title":"PGC-1alpha, mitochondrial dysfunction, and Huntington's disease","volume":"62","author":"Johri","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbrc.2016.07.058_bib150","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1523\/JNEUROSCI.6407-11.2012","article-title":"PGC-1alpha negatively regulates extrasynaptic NMDAR activity and excitotoxicity","volume":"32","author":"Puddifoot","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib151","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.4003","article-title":"PPAR-delta is repressed in Huntington's disease, is required for normal neuronal function and can be targeted therapeutically","volume":"22","author":"Dickey","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2016.07.058_bib152","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.tem.2016.02.008","article-title":"Unraveling the effects of PPARbeta\/delta on insulin resistance and cardiovascular disease","volume":"27","author":"Vazquez-Carrera","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2016.07.058_bib153","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0896-6273(03)00366-0","article-title":"Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1","volume":"39","author":"Tang","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2016.07.058_bib154","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1523\/JNEUROSCI.4411-08.2009","article-title":"Neuroprotective effects of inositol 1,4,5-trisphosphate receptor C-terminal fragment in a Huntington's disease mouse model","volume":"29","author":"Tang","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib155","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2013.11.016","article-title":"Ryanodine receptors as leak channels","volume":"739","author":"Guerrero-Hernandez","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2016.07.058_bib156","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1046\/j.0953-816x.2001.01767.x","article-title":"Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene","volume":"14","author":"Hansson","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbrc.2016.07.058_bib157","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbrc.2012.10.107","article-title":"Calcium leak through ryanodine receptor is involved in neuronal death induced by mutant huntingtin","volume":"429","author":"Suzuki","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2016.07.058_bib158","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1093\/brain\/awv188","article-title":"Increased TRPC5 glutathionylation contributes to striatal neuron loss in Huntington's disease","volume":"138","author":"Hong","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.bbrc.2016.07.058_bib159","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.bbadis.2011.11.014","article-title":"Antioxidants in Huntington's disease","volume":"1822","author":"Johri","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2016.07.058_bib160","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/ncb0609-669","article-title":"STIMulating store-operated Ca(2+) entry","volume":"11","author":"Cahalan","year":"2009","journal-title":"Nat. Cell Biol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X16311731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X16311731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T07:56:49Z","timestamp":1718697409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X16311731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":160,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0006291X16311731"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.07.058","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Striatal synaptic dysfunction and altered calcium regulation in Huntington disease","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.07.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}